Ligand validation:3F9Y

SAH: S-ADENOSYL-L-HOMOCYSTEINE

SAH is a Ligand Of Interest in 3F9Y designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3F9Y_SAH_A_801	90%	22%	0.084	0.965	1.59	1.65	4	5	0	0	100%	1
3F9Y_SAH_B_801	88%	29%	0.077	0.952	1.24	1.6	3	4	0	0	100%	1
3F9W_SAH_A_801	99%	36%	0.053	0.986	1.08	1.41	2	4	0	0	100%	1
1ZKK_SAH_B_2801	97%	38%	0.067	0.983	1.09	1.32	2	1	0	0	100%	1
3F9X_SAH_B_801	96%	46%	0.076	0.987	0.97	1.13	3	3	0	0	100%	1
3F9Z_SAH_A_801	85%	31%	0.099	0.964	1.34	1.4	2	2	0	0	100%	1
2OB2_SAH_A_1801	100%	22%	0.023	0.994	1.25	1.94	3	4	0	0	100%	1
2BB3_SAH_B_203	100%	9%	0.027	0.993	2.32	2.18	9	6	4	0	100%	1
3LGA_SAH_B_301	100%	22%	0.027	0.994	1.32	1.89	2	3	0	0	100%	1
4QPP_SAH_A_1000	100%	37%	0.025	0.995	0.99	1.46	2	4	0	0	100%	1
8QXQ_SAH_A_401	100%	51%	0.028	0.994	0.84	1.04	1	2	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.